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Abstract
Reduction of health disparities and advancement of health equity in the United States require high-
quality data indicative of where the nation stands vis-à-vis health equity, as well as proper analytic 
tools to facilitate accurate interpretation of these data. This article opens with an overview of 
health equity and social determinants of health. It then proposes a set of recommended practices in 
measurement of health disparities, health inequities, and social determinants of health at the 
national level to support the advancement of health equity, highlighting that (1) differences in 
health and its determinants that are associated with social position are important to assess; (2) 
social and structural determinants of health should be assessed and multiple levels of measurement 
should be considered; (3) the rationale for methodological choices made and measures chosen 
should be made explicit; (4) groups to be compared should be simultaneously classified by 
multiple social statuses; and (5) stakeholders and their communication needs can often be 
considered in the selection of analytic methods. Although much is understood about the role of 
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social determinants of health in shaping the health of populations, researchers should continue to 
advance understanding of the pathways through which they operate on particular health outcomes. 
There is still much to learn and implement about how to measure health disparities, health 
inequities, and social determinants of health at the national level, and the challenges of health 
equity persist. We anticipate that the present discussion will contribute to the laying of a 
foundation for standard practice in the monitoring of national progress toward achievement of 
health equity.
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surveillance
Since the 1980s, there has been a growing call for nations across the globe to address health 
inequities, which are systematic, unfair, and avoidable differences in health outcomes and 
their determinants between segments of the population, such as by socioeconomic status 
(SES), demographics, or geography.1,2 A seminal paper by Margaret Whitehead3 in 1992 
created international urgency for governments and all sectors of society to attend to 
differences in health that have been found to be associated with social position. Social 
position can be defined as “relative advantage and disadvantage in social 
hierarchies.”1(p180) Differences in health associated with social position can be considered 
unfair because they affect groups of people who are already at a disadvantage.4 In 2005, the 
World Health Organization (WHO) established the Commission on Social Determinants of 
Health to draw attention to the conditions of living that underlie inequitable differences in 
health. Social determinants of health are the “conditions in which people are born, grow, 
live, work and age. These circumstances are shaped by the distribution of money, power and 
resources at global, national and local levels.”5 The Commission on Social Determinants of 
Health’s final report was completed in 2008, and it reported that “within countries, the 
differences in life chances are dramatic and are seen in all countries—even the 
richest.”6(preface)
In the United States, a 1985 report by the US Department of Health and Human Services 
(HHS), the Secretary’s Task Force Report on Black and Minority Health, showed pervasive 
racial and ethnic differences in health outcomes,7 and this sparked concern nationwide. 
Decades later, in 2003, the Institute of Medicine report, Unequal Treatment: Confronting 
Racial and Ethnic Disparities in Healthcare, showed troubling racial and ethnic inequities in 
health care.8 The socioeconomic gradient of health is also well established in the United 
States and worldwide. For example, decades of research show a dose-response relationship 
between educational attainment and health in the United States. That is, the relationship 
between social advantage and health is incremental—with less advantaged groups 
experiencing a disproportionate burden of poor health and even relatively advantaged groups 
showing a deficit.9 Systematic differences in health based on race/ethnicity, sex, gender 
identity and sexual orientation, SES, age, disability status, geography, and primary 
language10 (among other characteristics) persist in the United States to the current day. 
Inasmuch as eliminating these differences—particularly those that are “avoidable or 
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remediable”—remains a public health priority, a focus on health equity is no less timely now 
than it was in the 1980s. Addressing health equity has also been identified as an ethical 
imperative. Paula Braveman and Sir Michael Marmot, leaders in the field, have asserted, 
respectively, that “it is an ethical responsibility and consonant with principles of human 
rights to give special priority to action on important public-health problems that 
differentially affect those with fewer resources and/or greater obstacles to addressing 
problems”11(p185) and “the case is moral—reducing health inequities and improving health 
is a duty and should be a priority for governments and those with influence to improve 
health.”12(pS519)
The past several years have been characterized by an increasing focus on solutions (eg, see 
the reports by Meyer et al10 and Penman-Aguilar et al13). Health in All Policies is a 
“collaborative approach to improving the health of all people by incorporating health 
considerations into decision-making across sectors and policy areas.”14 This and other 
developments such as community-level interventions to address the social determinants of 
health and health systems changes to reduce health care inequities show promise.15
What is not measured cannot readily be remedied; thus, the provision of accurate and useful 
data is foundational.16 Many of the examples in this article are drawn from 2 priority 
national initiatives that provide such information and whose scopes include monitoring 
health disparities (including inequities) and social determinants of health—Healthy People 
and CDC (Centers for Disease Control and Prevention) Health Disparities and Inequalities 
Reports (CHDIRs).
At a national level in the United States, the Healthy People 2020 initiative sets national 
health objectives with benchmarks and monitors differences across population subgroups to 
advance the attainment of health equity. At its launch in 2010, Healthy People 2020 
identified “achieve health equity, eliminate disparities and improve health of all groups” as 
one of its 4 overarching goals. The Healthy People 2020 definition of health equity is 
broader than the definition of inequities provided earlier, and it includes the “attainment of 
the highest level of health for all people. Achieving health equity requires valuing everyone 
equally with focused and ongoing societal efforts to address avoidable inequalities, historical 
and contemporary injustices, and the elimination of health and health care disparities.”17 
Healthy People 2020 includes social determinants of health as one of its 12 leading health 
indicator topics and one of its 42 topic areas, reflecting the importance of conditions of 
living for health.18
CHDIRs provide “analysis and reporting of recent trends and ongoing variations in health 
disparities and inequalities for selected social and health indicators.”19 The inaugural 
CHDIR was published in 2011.20 The most recent CHDIR reported on 29 topics, including 6 
that represent social or environmental determinants of health.19
The present discussion lays a foundation of recommended practices in measurement of 
health disparities, health inequities, and social determinants of health at the national level to 
support the advancement of health equity. The task is to routinely collect high-quality data 
indicative of where we stand as a nation, analyze it appropriately, and present it in ways that 
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are meaningful to the broad spectrum of audiences upon whose effort the achievement of 
health equity depends. Although the article is primarily targeted to researchers interested in 
national systems for monitoring indicators of health equity (governmental or private), those 
involved in monitoring indicators of health equity at lower levels of geography (eg, state 
health departments) should find it useful, as should anyone who seeks to compare 
populations on specific health outcomes or determinants at national or subnational levels.
Two events led to the development of this article. First, CDC has convened a series of annual 
forums to engage public health scientists and practitioners in a shared vision of how the 
agency can contribute to the elimination of health disparities and the advancement of health 
equity. The 2013 forum focused on measurement and monitoring of health disparities, health 
inequities, and social determinants of health. On the basis of knowledge of the literature, the 
authors of this article outlined key principles of measurement in advance of this forum. 
These principles framed the presentations and question and answer sessions at the forum. A 
second pertinent event was the recent adoption by the Advisory Committee to the CDC 
Director (a group of external advisors) of a set of recommendations proposed by the Health 
Disparities Subcommittee of the Advisory Committee to the CDC Director (HDS). One of 
these recommendations was that CDC identify and monitor indicators of health equity. The 
CHDIRs have been CDC’s primary mechanism for reporting on national-level health 
equity–related indicators. Notably, the HDS commented on the need for greater attention to 
within-group heterogeneity in the CHDIRs, and attending to this heterogeneity is an 
emphasis of this article. Considering how one might adapt CDC’s reporting to address the 
HDS recommendation required a careful review of the literature. To this end, the lead author 
reviewed literature on measurement of health equity 121 sources were reviewed; these were 
chosen upon recommendation by authors and other subject matter experts), extracted 
“practices” (often congruent with the list developed for the 2013 forum), and shared them 
with coauthors and other subject matter experts for comment. When agreement was reached, 
the list of practices was finalized. As part of this process, practices were sometimes 
combined, split apart, or renamed to make them as intuitive as possible to the reader. The 
result was a set of recommended practices that we assert require consideration in the 
development of any set of indicators intended to assess the state of health equity in the 
United States.
It is beyond the scope of this article to attempt to account for all of the innovation that is 
occurring at various levels of society (eg, in communities, cities, and states, and among 
American Indian/Alaska Native Tribes) in how to monitor and address structural and 
contextual factors that are at the origin of inequities in health and health care. Even after 
such factors are identified through comprehensive research and analysis, the future of health 
equity remains dependent on continued innovation in developing methods to monitor them 
and intervene.
A Note About Terminology
Health disparities have been described as “differences in health outcomes and their 
determinants between segments of the population, as defined by social, demo graphic, 
environmental, and geographic attributes.”20* Although this definition of “health disparity” 
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does not imply that something is avoidable or unfair, we consider reductions in health 
disparities to generally reflect progress toward health equity. Consistent with the definition 
provided earlier, we prefer the term “inequity” for those differences that are systematic, 
unfair, and avoidable. Notably, the international literature often uses the term “inequalities” 
to describe differences across individuals or across groups. It is also often used in reference 
to particular summary measures, such as those borrowed from the field of economics.20
Recommended Practices for Measurement to Advance Health Equity
Practice 1: Assess differences in health and its determinants that are associated with 
social position
The normative nature of the concept of equity means that health equity cannot be measured 
directly.2,11,21 The concept of equity is closely tied to fairness and justice, and what is 
considered fair and just depends on social norms; these norms may vary from society to 
society.22 In addition, there may be multiple valid approaches to operationalizing the 
concept of equity within the same social context.1,21,23 Thus, health equity poses 
measurement challenges. One approach to this dilemma is to operationalize health equity as 
the absence of that which is inequitable. Accordingly, the WHO defines equity as “the 
absence of avoidable or remediable differences among groups of people, whether those 
groups are defined socially, economically, demographically, or geographically.”24 Others 
have taken this idea a step further to focus, more specifically, on differences in health and its 
determinants (including social determinants) that are systematically associated with lower 
social position, asserting that such differences are unfair because they affect groups of 
people who are already at a disadvantage.4
While this approach to monitoring progress toward health equity may be viewed by some as 
an oversimplification,21 measuring differences in health and its determinants (including 
social determinants) that are associated with social position and assessing change over time 
is a prerequisite for timely assessment of the effects of policies on the health of different 
segments of the population.1 This implies a priori identification of characteristics of groups 
of people that are associated with more/less power and privilege11 or with higher/lower 
social position. Some domains within which such characteristics may be identified include 
race/ethnicity, sex, sexual orientation and gender identity, age, SES (including educational 
level, income, wealth, and occupation), country of birth, disability status, and geographic 
location.25 Toward this end, historic and current experiences of disadvantage can be 
ascertained through examining government reports, academic literature, and credible media 
reports.4 It is worth noting that although one’s social position may vary by one’s sex or age, 
some systematic differences in health outcomes by sex (eg, breast cancer) or age (eg, 
Alzheimer’s disease) cannot be deemed inequities.
As an example, the population characteristics of interest addressed in the CHDIRs included 
race and ethnicity, sex, sexual orientation, age, disability, SES, and geographic location. 
Whenever possible, disparities in health outcomes and their determinants were analyzed 
along these dimensions. In the most recent CHDIR, the most common dimension examined 
*Available at: http://www.cdc.gov/mmwr/preview/mmwrhtml/su6001a2.htm?s_cid=su6001a2_w
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was race and ethnicity. Sexual orientation was examined for only one topic (HIV infection) 
because of data limitations.10
Practice 2: Assess social and structural determinants of health and consider multiple 
levels of measurement
There is preponderant evidence linking social determinants to health inequities in diverse 
settings and at different times in history12,26; social determinants explain some of the 
“avoidable or remediable” differences in health outcomes observed among groups with 
different social position. If we are to advance health equity and population health,9 then 
social determinants are critically important to monitor in their own right because they inform 
the prioritization of interventions that affect changes in these conditions. Rigorous 
monitoring of social determinants of health first requires understanding which social 
determinants are most important to monitor. For this reason, monitoring must be informed 
by prior research into the pathways through which social determinants affect health. 
Monitoring social determinants of health also necessitates moving beyond traditional health 
data sources. The practice of utilizing nonhealth data systems to monitor social determinants 
of health at the national level is still relatively uncommon and is far from routine, although 
some notable exceptions exist (eg, Healthy People 2020, as discussed earlier18).
Although considering social determinants of health measured at the individual level is 
important and illuminating, it is not a substitute for considering them at contextual levels 
(eg, neighborhood conditions), and vice versa. Decisions about the level of measurement 
should be made with care, and developing a rationale for choosing a particular level of 
measurement is essential. Structural determinants of health (including policies, programs, 
decision making/governance, and economics) require monitoring as well. Innovative 
approaches to assessing these important determinants of health have been proposed (eg, see 
the reports by Harrison and Dean27 and Sadana and Harper28).
Considering the 3 social determinants of health topic areas in the most recent CHDIR, the 
analysis of education and income relied on aggregated data collected at the individual level,
29
 as did the analysis of employment.30 The study of access to healthier food retailers used 
census tract–level data.31 Although rationales for choices of measurement level were not 
explicitly stated, they were implicit (in statements such as “purposes … are to discuss and 
raise awareness of differences in the characteristics of persons who are unemployed …”30) 
and multiple levels of measurement were used in the report as a whole, reflecting 
recognition that social determinants of health operate at multiple levels.
Practice 3: Provide reasons for methodological choices and clarify their implications
There is a need for better understanding—both among data analysts28 and among consumers 
of data32—of the weighty implications of analytic choices in measurement of health 
disparities, health inequities, and social determinants of health. Although providing reasons 
for methodological choices and clarifying their implications are important for any analysis 
undertaken in public health, experts in the field of health equity have emphasized this, 
perhaps because the potential for drawing different conclusions about health equity from the 
same data set has been described and demonstrated by Harper and colleagues,32–35 among 
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others. Bias can stem not only from the value preferences or habits that inform choice of 
measurement practice(s) but also from the effect that different data presentation approaches 
have on audience perceptions or judgments of the resulting meaning of the data or analysis. 
Some key early considerations in measurement that have important implications for later 
interpretation of findings include (a) the point from which differences will be measured (the 
reference point), (b) whether differences will be measured on an absolute or relative scale, 
(c) whether the size of the social group will be accounted for, (d) whether differences will be 
evaluated with a pair-wise or summary approach, (e) and whether extra emphasis should be 
given to social groups that are of greater concern through differential weighting. Other 
considerations apply as well, and we cite several reports (eg, see the reports by Harper et al,
33
 World Health Organization,36 and Keppel et al37) that the reader can use as a selected 
bibliography of relevant literature.
Reference point—There are several choices for a reference point—the rate or other 
estimate from which differences are measured (for simplicity, we will refer to rates). Some 
of the options for a reference point include the largest social group, the social group with the 
most favorable rate for a health outcome or determinant, the group with the greatest social 
advantage, the total population, and a target chosen through a planning process, among 
others.11,37
A major health equity consideration in choosing a reference point for public health analyses 
is the level of health and its determinants one wishes to see achieved. For example, in the 
Healthy People 2020 framework, a lack of systematic differences among population groups 
is not sufficient to demonstrate health equity; the population also needs to be faring well. 
Under this framework, the total population level of a particular health outcome or 
determinant might not be the most appropriate reference point for evaluating progress 
toward health equity. Accordingly, Healthy People 201037 (and, subsequently, Healthy 
People 2020) used the group with the most favorable (or, alternatively, the least adverse) rate 
to highlight opportunities for improvement.
Absolute versus relative scale—Considering one scale versus the other can lead to 
different conclusions. For example, in the Figure, age-adjusted breast cancer death rates are 
decreasing for both non-Hispanic white and non-Hispanic black women. The simple 
difference (an absolute measure of disparity) between the rates also has decreased, by 0.8 
per 100 000 (35.1 − 26.0 = 9.1 in 2001 vs 29.2 − 20.9 = 8.3 in 2013), although this change 
was not statistically significant. However, when one considers the rate ratio (a common 
relative measure in the epidemiologic literature), the relative disparity* between the 2 groups 
has increased (rate ratio 35.1 ÷ 26.0 = 1.35 in 2001 is less than the ratio 29.2 ÷ 20.9 = 1.40 
in 2013).
Beyond the potentially diverging conclusions that result from using one scale versus the 
other, the choice of an absolute or relative scale commits the user to implicit value 
judgments that have been elucidated in detail elsewhere.32 Broadly speaking, the relative 
*Relative disparities also may be expressed as percent differences. For example, rate ratios of 1.0 or more are converted to percent 
differences by subtracting 1.0 and multiplying by 100%.
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scale does not take into account the magnitude of the underlying rates for the health outcome 
under consideration. Indeed, the rate ratio of 1.40 in 2013 would remain unchanged whether 
the breast cancer death rates for the 2 groups were doubled (58.4 ÷ 41.8 = 1.40) or halved 
(14.6 ÷ 10.4 = 1.40). On the contrary, the choice of the absolute scale reflects more concern 
with how each social group is faring on the health outcome and how the population is faring 
overall.
The simple difference between the 2 breast cancer death rates would not increase if the 
groups were to further improve in parallel. For example, if both rates were to demonstrate a 
10% improvement, consistent with the corresponding Healthy People 2020 objective,† from 
29.2 and 20.9 in 2013 to 26.3 and 18.8 in 2020, then the simple difference would decrease 
by an additional 0.8 per 100 000, from 8.3 to 7.5, which would reflect both an improvement 
in the groups’ health outcomes and a reduction in the gap between the groups.
For reasons that have been detailed elsewhere, both absolute and relative measures of 
disparity should be reported34,37 and considered in the assessment of progress toward health 
equity. The CHDIRs routinely present both relative and absolute measures of disparity, 
allowing the reader to take both into consideration in drawing conclusions.10,20
Accounting for group size—Measures of absolute or relative disparity are not sufficient 
for assessing the societal impact or burden of disparities, because the assessment of impact 
requires a “head count”—the number of persons affected in each group—a concept closely 
related to the size of groups.
Group size also is pertinent to the question of differential weighting, which is further 
discussed later. When all groups are weighted equally, irrespective of their size, an 
intervention that targets a relatively small group with a relatively large burden of disease can 
prove very effective in reducing measures of overall disparity. On the contrary, when groups 
are weighted according to their size, that same intervention will not have as much impact on 
reducing measures of overall disparity. This trade-off between individuals’ and groups’ 
burden of disease is referred to as the “health inequality paradox.”38,39
Pair-wise versus summary approach—Population breakdown by race and ethnicity, 
education, or income often results in 3 or more groups for comparison relative to the 
reference point. The resulting pair-wise differences between groups can be combined using 
summary measures. Summary measures have a long history and have been reviewed in the 
health economics literature (eg, see the reports by Wagstaff et al40 and Mackenbach et al41). 
Recent comparative studies of summary measures continue to explore their qualitative and 
quantitative features (eg, see the reports by Harper et al,33 Levy et al,42 and Talih43).
Summary measures are useful in that they quantify the relationship between the distributions 
of health outcomes and population shares. Summary measures are especially useful when 
comparisons among numerous populations as well as among different time periods are 
†Healthy People 2020 objective C-3, to reduce the female breast cancer death rate, targets a 10% improvement in the age-adjusted 
breast cancer death rate, nationally, from 23.0 deaths per 100 000 population in 2007 to 20.7 per 100 000 by 2020. See http://
www.healthypeople.gov/node/4069/data details.
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desired, because the alternative option of multiple pair-wise comparisons over time can be 
difficult to interpret. As an example, if non-Hispanic whites, non-Hispanic blacks, 
Hispanics, Asians (non-Hispanic), Pacific Islanders (non-Hispanic), and American Indians/
Alaska Natives (non-Hispanic) were compared with the population average on a particular 
health outcome over time, there would be 6 different comparisons to monitor, whereas a 
summary measure monitored over time could indicate whether, overall, racial and ethnic 
differences for that outcome were increasing or decreasing over time.
Because many summary measures are centered on the relation between the distributions of 
health outcomes and population shares, they do not account for the association between SES 
and health outcomes. To address this need, the measurement literature includes the 
development of summary measures that account for the socioeconomic gradient.44–47
Differential weighting—Because of the “unfavorable social, economic, or political 
conditions that some groups of people systematically experience based on their relative 
position in social hierarchies,”23(pS151) some social groups may be deemed to be of greatest 
concern and merit extra emphasis (eg, in the design of interventions, applying a tailored 
approach to complement a universal approach48). Differential weighting can provide the 
analyst with the measurement tool to account for this. For example, if we consider it more 
inequitable when groups with lower SES experience worse health outcomes than groups 
with higher SES (vs the reverse situation of groups with higher SES showing worse 
outcomes), we can use socioeconomic health inequality measures to put more weight on 
groups with lower SES.
Measurement choices of a reference point, absolute versus relative scale, whether to account 
for group size, whether to adopt a pair-wise versus summary approach, and whether to use 
differential weighting affect the findings, which, in turn, affect conclusions drawn as to 
whether there are inequities and whether or not they have changed. Different conclusions 
can lead to different public health priorities and actions.34 For example, the trade-off 
between individuals’ and groups’ burden of disease (ie, health inequality paradox) means 
that conclusions about the potential impact of public health interventions can be very 
different depending on the measures used. All those who act to advance health equity 
(including government, communities, researchers and academia, and the private sector) 
would benefit from clear understanding that conclusions drawn about health equity heavily 
depend on the measures used.
Data analysts and those who design systems to monitor progress toward health equity can 
make reasoned methodological choices a priori, provide reasons for the choices, and clearly 
explain what findings mean33 to foster greater understanding of findings among those who 
must act on them.
Practice 4: Address within-group heterogeneity by comparing groups simultaneously 
classified by multiple social statuses
Because groups defined on the basis of social position show substantial internal 
heterogeneity in health and the conditions underlying health, multiple social statuses must be 
accounted for simultaneously in monitoring progress toward health equity. Only then is it 
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possible to attend to the health of those with “fewer resources and/or greater obstacles to 
addressing problems”11(p185)—an orientation that necessarily underlies efforts to achieve 
health equity.
For example, in the United States, African Americans and Latinos have “less wealth at every 
level of income [and] higher exposure to occupational risks within the same occupational 
categories.”49(p1260) A particular source of heterogeneity among immigrant populations is 
length of time in the United States. Time since immigration moderates associations between 
SES and health risks and outcomes, with stronger associations being evident among those 
who have resided in the United States for longer periods of time. The same relationships 
hold for second- and later generation immigrants as compared with first-generation 
immigrants. Importantly, SES does not fully account for differences in health outcomes by 
race/ethnicity. Accounting for SES in an analysis can lessen apparent disparities by race/
ethnicity, but it generally does not eliminate them.49,50
In the US context, attending to heterogeneity involves monitoring health and determinants at 
the intersection of race and ethnicity, SES, and sex. For population groups with a high 
proportion of immigrants (eg, Hispanics and Latinos), consideration of country of birth (eg, 
US-born vs foreign-born) and generational status (eg, first or second generation) are 
important, given that health may differ markedly along these dimensions, with, for example, 
foreign-born Hispanics and Latinos showing overall better health than their US-born 
counterparts.51 Other intersections require attention as well (eg, race/ethnicity, sex, and 
disability status; race/ethnicity, sex, and sexual orientation).
The CHDIRs have accounted for within-group heterogeneity for some topics but not for 
others.10,20 Although not a monitoring effort, an example of a national-level assessment that 
took heterogeneity into account was CDC’s first Vital Signs Morbidity and Mortality 
Weekly Report (MMWR) on Hispanic health.51 This nationally representative study 
compared Hispanics, Hispanic origin subgroups (eg, Cuban, Puerto Rican), and non-
Hispanic whites by nativity (US-born vs foreign-born) and sex on causes of death, 
prevalence of disease and risk factors, and use of health services.
Practice 5: The need to communicate to a wide array of stakeholders can often be taken 
into consideration in the choice of measures and analytic methods
While other considerations, such as rigor, are primary, stakeholders and their communication 
needs can often be considered in the selection of measures and analytic methods. (As noted 
earlier, key actors in health equity include government, communities, researchers and 
academia, and the private sector.6) This is a delicate balance, however, and it cannot be 
emphasized enough that considering the needs of stakeholders creates the potential, intended 
or unintended, to bias the results and conclusions drawn. Thus, practice 5 is intimately tied 
to practice 3 (Provide reasons for methodological choices and clarify their implications). As 
noted in that section, implications can include effects on audience perceptions or judgments, 
and transparency is critical.
Benchmarking is a rigorous measurement practice that is intuitive in its appeal to a broad set 
of audiences. The WHO’s Gender, Health Equity and Human Rights Team promotes the use 
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of benchmarking to place changes over time in context.36 Similarly, in the United States, the 
HHS Agency for Healthcare Research and Quality National Healthcare Quality and 
Disparities Reports52 estimate national benchmarks based on the average values for the 10% 
of states that have the best outcomes for a measure of interest. Differences between 
population groups can then be understood in the context of the projected time expected for 
these groups to achieve the designated benchmark, assuming that past trends continue.
For example, on the basis of 2008 data for the top 5 states, the 2013 Agency for Healthcare 
Research and Quality National Healthcare Disparities Report53 estimates that the achievable 
benchmark for female breast cancer deaths was 17 per 100 000 population (age-adjusted) 
and that, as of 2010, white women could achieve this benchmark in 9 years whereas black 
women could achieve it in 28 years. Time to achieve benchmark is a measure that is not only 
rigorous but also useful for audiences who seek to call attention to and mobilize action to 
address health inequities.
Discussion
The article aims to make explicit underlying concepts of health equity and challenges and 
opportunities associated with assessing and monitoring progress toward meeting the national 
goal of achieving health equity.
Measuring progress toward health equity is necessary
An overarching public health goal of the United States is to eliminate disparities in health 
and health care to improve the overall health of the nation and achieve health equity 
(Healthy People 2020). The 2011 Action Plan committed public health practitioners and 
policy makers to realize these goals at the national, state, and local levels.54
Accurate and timely assessment and monitoring of the magnitude and direction of change of 
health disparities and their determinants are necessary for public health evaluation of 
progress toward the US goals (Healthy People 2020). Increasingly, health disparities are 
showing stagnation or a widening of the “gap,” which is consistent with the “inverse equity 
hypothesis” that initially the benefit of interventions accrues to the more advantaged groups.
55
 Eventually, the magnitude of inequality declines with increasing access to the 
interventions by the more disadvantaged groups. Evidence from systematic reviews suggests 
that this phenomenon is not inevitable: “downstream” prevention interventions (directed at 
individual-level factors) are more likely than “upstream” interventions (directed at social or 
policy-level factors) to increase health disparities.56
Recognizing that measurement decisions will influence the results is important
Numerous measures for macro- and microlevel indicators have been suggested. Typically, 
health disparities are reported as relative measures (as ratios) derived by comparing the 
groups with the poorest and best levels of health. A recent review of studies reported in 
major journals showed that the use of relative measures of effect remains a common 
practice: almost 90% of studies reporting health disparities used relative measures.35 As 
discussed previously, the choice of the scale used may lead to different conclusions and 
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reflects implicit value judgments. As a result, the choice of measurement scale may 
influence findings and hence policy formulation and allocation of resources.
Indeed, a suite of measures provides the most holistic picture of health disparities. A seminal 
monograph sponsored by the National Cancer Institute recommended employing a variety of 
measures on the same data to ensure a triangulated depiction of health disparities.34 This 
monograph laid the groundwork for the so-called Health Disparities Calculator (HD*Calc), 
developed by the National Cancer Institute as statistical software for calculating multiple 
measures to monitor and examine health disparities related to cancer. HD*Calc calculates 11 
measures of health disparities that vary according to scale (absolute or relative), reference 
group, weighting, etc.57
More recently, the National Center for Health Statistics, in collaboration with the HHS 
Office of Disease Prevention and Health Promotion and HHS Office of Minority Health, has 
developed an online tool to help Healthy People 2020 stakeholders describe and analyze 
health disparities data. Publicly released in Spring 2015, the health disparities tool (“HD 
tool,” for short) is a new feature of the http://healthypeople.gov Web site designed to 
summarize health disparities as well as changes in disparities over time for all measurable 
population-based Healthy People 2020 objectives with available data. The HD tool produces 
detailed pair-wise comparisons, summaries of health disparities by population groups (eg, by 
sex, race/ethnicity, educational attainment, or family income), and graphical displays to 
visualize disparities as well as changes in disparities over time. The HD tool summary 
measures include both absolute and relative measures of disparity: simple difference 
between highest and lowest rates; ratio between highest and lowest rates; and a rate ratio 
between the best group rate and the average rate for all other groups. Other suites of 
measures have been developed as well.43,47
Currently, social determinants of health are often defined by individual attributes (eg, 
gender, educational attainment, poverty status, disability status)
This approach is unlikely to be sufficient to meet national goals to achieve health equity. 
Given that health inequities arise from the “immediate and structural conditions in which 
people are born, grow, live, work, and age,”58(p1661) it will be necessary to generate 
analytic data sets that routinely capture structural and contextual factors that are the origins 
of inequities in health and health care.59,60
It is critical that public health, in collaboration with health care and other sectors, continue 
to advance understanding of social determinants of health and the pathways through 
which they operate on specific health outcomes
Identifying these root causes, particularly those that impact a wide variety of health 
outcomes, can contribute to effective and efficient use of limited public health resources.
12,26
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Although improvements are regularly being made by various agencies and organizations, 
some national data systems are currently limited in many ways
Sample sizes are one obvious issue, especially for smaller demographic groups and 
geographies that may be of particular interest when considering issues related to equity. For 
some important characteristics, such as gender identity, sexual orientation, and disability 
status, the measurement of the characteristic itself has not yet been standardized, or in some 
cases implemented, across national data systems, although progress is being made.
Many public health researchers have little experience with the concepts of health equity 
and the measures discussed herein
Reduction of health disparities and progress to health equity are achievable if intensive and 
systematic training is available for the workforce at the national, state, and local levels.
Conclusions
Over the decades since the clarion call for health equity was raised domestically by the 
Secretary’s Task Force Report on Black and Minority Health7 and internationally by the 
writings of Margaret Whitehead3 and others, much has been learned about how to measure 
health disparities, health inequities, and social determinants of health at the national level to 
support the advancement of health equity. Nevertheless, there is still much to learn and 
implement, and the challenges of health equity persist. As the field of health equity 
continues to evolve, we anticipate that the present discussion will contribute to the laying of 
a foundation for standard practice in the monitoring of national progress toward achievement 
of health equity.
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FIGURE. Female Breast Cancer Deaths, 2001–2013a
Abbreviation: ICD-10, International Classification of Diseases, Tenth Revision. aData are for 
ICD-10 code C50 reported as underlying cause of death and are age-adjusted using the year 
2000 standard population. Prior to 2003, only 1 race category could be recorded; recording 
more than 1 race was not an option. Beginning in 2003, multiple-race data were reported by 
some states; multiple-race data were bridged to the single-race categories for comparability. 
From National Vital Statistics System–Mortality, National Center for Health Statistics, 
Centers for Disease Control and Prevention.
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